Tarón M - Search Results

1

Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?

Camps C, Sirera R, Bremnes R, Blasco A, Sancho E, Bayo P, Safont MJ, Sánchez JJ, Tarón M, Rosell R. Camps C, et al. Among authors: taron m. Lung Cancer. 2005 Dec;50(3):339-46. doi: 10.1016/j.lungcan.2005.06.007. Epub 2005 Sep 1. Lung Cancer. 2005. PMID: 16139926

2

DNA repair and cisplatin resistance in non-small-cell lung cancer.

Rosell R, Lord RV, Taron M, Reguart N. Rosell R, et al. Among authors: taron m. Lung Cancer. 2002 Dec;38(3):217-27. doi: 10.1016/s0169-5002(02)00224-6. Lung Cancer. 2002. PMID: 12445742 Review.

3

Genetic testing for chemotherapy in non-small cell lung cancer.

Rosell R, Taron M, Alberola V, Massuti B, Felip E. Rosell R, et al. Among authors: taron m. Lung Cancer. 2003 Aug;41 Suppl 1:S97-102. doi: 10.1016/s0169-5002(03)00151-x. Lung Cancer. 2003. PMID: 12867068 Review.

4

Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer.

Alberola V, Sarries C, Rosell R, Taron M, de las Peñas R, Camps C, Massuti B, Insa A, Garcia-Gomez R, Isla D, Artal A, Muñoz MA, Cobo M, Bover I, Gonzalez-Larria JL, Terrasa J, Almenar D, Barcelo R, Diz P, Sanchez-Ronco M, Sanchez JJ. Alberola V, et al. Among authors: taron m. Clin Lung Cancer. 2004 May;5(6):360-5. doi: 10.3816/clc.2004.n.014. Clin Lung Cancer. 2004. PMID: 15217535 Clinical Trial.

5

Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer.

Rosell R, Ichinose Y, Taron M, Sarries C, Queralt C, Mendez P, Sanchez JM, Nishiyama K, Moran T, Cirauqui B, Mate JL, Besse B, Reguart N, Perez M, Sanchez JJ. Rosell R, et al. Among authors: taron m. Lung Cancer. 2005 Oct;50(1):25-33. doi: 10.1016/j.lungcan.2005.05.017. Lung Cancer. 2005. PMID: 16011858

6

Quantification in the serum of the catalytic fraction of reverse telomerase: a useful prognostic factor in advanced non-small cell lung cancer.

Camps C, Sirera R, Bremnes RM, Ródenas V, Blasco A, Safont MJ, Garde J, Juarez A, Caballero C, Sanchez JJ, Taron M, Rosell R. Camps C, et al. Among authors: taron m. Anticancer Res. 2006 Nov-Dec;26(6C):4905-9. Anticancer Res. 2006. PMID: 17214360 Free article.

7

Gene expression and polymorphisms of DNA repair enzymes: cancer susceptibility and response to chemotherapy.

Camps C, Sirera R, Iranzo V, Tarón M, Rosell R. Camps C, et al. Among authors: taron m. Clin Lung Cancer. 2007 May;8(6):369-75. doi: 10.3816/CLC.2007.n.017. Clin Lung Cancer. 2007. PMID: 17562237 Review.

8

Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.

Carcereny E, Ramirez JL, Sanchez-Ronco M, Isla D, Cobo M, Moran T, de Aguirre I, Okamoto T, Wei J, Provencio M, Lopez-Vivanco G, Camps C, Domine M, Alberola V, Sanchez JM, Massuti B, Mendez P, Taron M, Rosell R. Carcereny E, et al. Among authors: taron m. Lung Cancer. 2010 Jun;68(3):491-7. doi: 10.1016/j.lungcan.2009.08.004. Epub 2009 Sep 5. Lung Cancer. 2010. PMID: 19733931 Clinical Trial.

9

First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients.

Salazar F, Molina MA, Sanchez-Ronco M, Moran T, Ramirez JL, Sanchez JM, Stahel R, Garrido P, Cobo M, Isla D, Bertran-Alamillo J, Massuti B, Cardenal F, Manegold C, Lianes P, Trigo JM, Sanchez JJ, Taron M, Rosell R. Salazar F, et al. Among authors: taron m. Lung Cancer. 2011 Apr;72(1):84-91. doi: 10.1016/j.lungcan.2010.07.008. Epub 2010 Aug 11. Lung Cancer. 2011. PMID: 20705357

10

Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC.

Jantus-Lewintre E, Sanmartín E, Sirera R, Blasco A, Sanchez JJ, Tarón M, Rosell R, Camps C. Jantus-Lewintre E, et al. Among authors: taron m. Lung Cancer. 2011 Nov;74(2):326-31. doi: 10.1016/j.lungcan.2011.02.016. Epub 2011 Apr 9. Lung Cancer. 2011. PMID: 21481963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters